Editorial: The development of lethal prostate cancer.

Zhang, Baotong; Qu, Sifeng; Li, Xin; Ci, Xinpei; Chang, Jiang

Zhang, Baotong; Qu, Sifeng; Li, Xin; Ci, Xinpei; Chang, Jiang.

Afiliación

Zhang B; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Qu S; Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Li X; Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Ci X; Center for Cancer Research and Therapeutic Development and Department of Biological Sciences, Clark Atlanta University, Atlanta, GA, United States.
Chang J; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

Front Cell Dev Biol ; 11: 1156392, 2023.

Article en En | MEDLINE | ID: mdl-36895791

Palabras clave

NEPC; PSMA-based PET imaging; biopsy; natural product; phenotypic plasticity; prostate cancer; therapeutic resistance; tumor microenvironment (TME)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google